Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2015-11-30
2021-08-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ECG Belt vs. Echocardiographic Optimization of CRT
NCT03305692
ECG Optimization of CRT: Evaluation of Mid-term Response
NCT01439529
Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
NCT04083690
Effects of CRT Optimization as Assessed by Cardiac MR
NCT04763460
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
NCT01466621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRT sub-optimal responder
Subjects who have had CRT for at least 6 months and who have not responded as well as they could, in their cardiologists opinion. Subjects' ejection fraction are still \<50% despite CRT. A ECG Vest Optimization protocol will be utilized as one aspect to determine the best CRT programming for each individual subject.
ECG Vest Optimization
As part of a standard and clinically indicated CRT optimization procedure utilize an ECG Vest as one modality for collecting information to determine best device programming.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ECG Vest Optimization
As part of a standard and clinically indicated CRT optimization procedure utilize an ECG Vest as one modality for collecting information to determine best device programming.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is or will be followed clinically in the UHVC CRT Optimization Clinic
* Patient has been implanted with a CRT device for at least 6 months
* Patient received an echocardiogram prior to CRT implant
* Patients must be ≥ 18 years of age
Exclusion Criteria
* Patients who are pregnant
* Patient has unhealed / open wounds on the torso and/or has a history of severe allergic reactions from ECG gel / electrode glue
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic
INDUSTRY
Alan J. Bank, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alan J. Bank, MD
Medical Director of Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alan J Bank, MD
Role: PRINCIPAL_INVESTIGATOR
Medical Director of Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
United Heart & Vascular Clinic
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
767654-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.